Sep 24, 2026 08:02AM
Sep 24, 2026 08:00AM
Aug 4, 2025 08:03AM
Aug 4, 2025 08:00AM
Apr 14, 2025 08:00AM
Mar 7, 2025 04:45PM
Dec 18, 2024 12:05PM CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
Dec 18, 2024 08:00AM
Nov 6, 2024 04:30PM
Oct 24, 2024 10:50AM
Oct 7, 2024 08:00AM
Sep 25, 2024 08:03AM
Sep 25, 2024 08:00AM
Sep 23, 2024 08:09AM Ainos (AIMD) Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Sep 20, 2024 08:00AM
Sep 17, 2024 08:09AM
Sep 17, 2024 08:00AM
Aug 5, 2024 04:15PM
May 13, 2024 04:10PM
Mar 8, 2024 04:20PM
Feb 5, 2024 09:05AM Ainos (AIMD) Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
Feb 5, 2024 09:00AM
Nov 28, 2023 08:30AM
Nov 21, 2023 08:32AM
Nov 21, 2023 08:30AM
Nov 9, 2023 04:30PM
Sep 19, 2023 12:26PM
Sep 18, 2023 07:03AM Ainos (AIMD) Granted FDA Orphan Drug Designation for VELDONA
Sep 18, 2023 07:00AM
Nov 7, 2022 07:30AM
Nov 3, 2022 07:00AM
Oct 31, 2022 07:00AM
Sep 30, 2022 07:02AM
Sep 30, 2022 07:00AM
Aug 24, 2022 07:02AM Ainos (AIMD) Submits INDA to FDA for Phase 2 Trial of VELDONA
Aug 24, 2022 07:00AM
Aug 17, 2022 08:05AM
Aug 15, 2022 07:20AM
Aug 11, 2022 02:12PM
Jun 27, 2022 07:00AM

332,018 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All